Neil S Oconnor in Isle Of Palms, SC - Podiatrist

Neil S Oconnor is a Podiatrist based in Isle Of Palms, South Carolina. Neil S Oconnor is licensed to practice in South Carolina (license number 153) and their current practice location is 402 Palm Blvd, Isle Of Palms, South Carolina. It can be reached at their office (for appointments etc.) via phone at (843) 270-7903.

NPI number for Neil S Oconnor is 1316076607 and their current mailing address is 800 Tiffany Blvd Ste 101, Rocky Mount, North Carolina. Neil S Oconnor does not participate in medicare program and thus does not accept medicare assignments. The facility's NPI Number is 1316076607.

Contact Information

	Neil S Oconnor
	402 Palm Blvd, Isle Of Palms, SC 29451-2146
	(843) 270-7903
	Not Available

Healthcare Provider's Profile

Full Name	Neil S Oconnor
Type	Facility
Speciality	Podiatrist
Location	402 Palm Blvd, Isle Of Palms, South Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. The facility may not accept medicare assignment.

NPI Data:

NPI Number: 1316076607
Provider Enumeration Date: 03/05/2007
Last Update Date: 04/29/2015

Medical Identifiers

Medical identifiers for Neil S Oconnor such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1316076607	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
213E00000X	Podiatrist	153 (South Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Neil S Oconnor is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Neil S Oconnor 800 Tiffany Blvd Ste 101, Rocky Mount, NC 27804-1807 Ph: (252) 985-1371	Neil S Oconnor 402 Palm Blvd, Isle Of Palms, SC 29451-2146 Ph: (843) 270-7903

News Archive

Findings suggest adipose inflammation is necessary for fat cell turnover

It has been a common opinion that inflammation in adipose tissue may cause insulin resistance, and thereby type 2 diabetes. However, recent research from the Swedish medical university Karolinska Institutet, published in the New England Journal of Medicine, question the theory that inflammation in the body fat is only pernicious.

Xenotransplantation – organ transplants from animals may soon be a reality

Researchers have been able to create genetically modified piglets that are cleaned of the viruses that could causes diseases in humans. This could open up new avenues in organs transplants from pigs to humans. The process of transplanting organs or tissues from animals to humans is called xenotransplantation. The report was published this Tuesday in the journal Science.

MRI awarded $31M NIH contract to provide chemistry support for National Toxicology Program

Midwest Research Institute (MRI), one of the nation's leading independent research organizations, with more than 65-years of experience in scientific research, has been awarded a $31 million contract from the National Institute of Environmental Health Sciences. Under the 5-year contract, MRI scientists will provide chemical procurement, handling, and analytical chemistry services requested by the National Toxicology Program (NTP) for toxicology studies in progress throughout the U.S.

Lumbar puncture, PET scan not useful to establish diagnosis of Alzheimer's

Investigators from the University of Amsterdam, Netherlands, have shown that in most elderly patients invasive and expensive techniques, i.e. lumbar puncture and PET scan, are not useful to establish the diagnosis of Alzheimer's disease. They arrived at this conclusion after analysis of data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a large collaborative research project of medical centers in the USA and Canada.

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

Neil S Oconnor - Podiatrist in Isle Of Palms, SC